Unilever Execs Quietly Selling Food Assets as Spin-Off Hype Rises—Smart Money Flags Red Flag

The headline story is a strategic pivot. Unilever is reportedly in talks to spin off its food business and combine it with spice maker McCormick in an all-stock deal. The goal, as the company has been signaling, is to streamline toward beauty and personal care-higher-margin categories where it sees stronger growth potential. This move would accelerate a retreat from food, where brands like Hellmann's and Knorr now account for roughly a quarter of revenue, down from over half a generation ago.

Yet the real signal is in the filings, not the press releases. While the stock market has been optimistic, with Unilever's shares ticking up 6.2% over the past 90 days, its own executives have been quietly taking money off the table. The company saw a net sell-off from insiders of approximately -$3.57 million in that same period, with executives alone contributing a net sales total of around -$2.44 million.

The sell-off extends to the other side of the proposed deal. McCormick's CEO, Brendan Foley, has been a major seller, selling 57,144 shares for an estimated $3.75 million in the past six months. In total, insider sales at McCormick have exceeded $4.4 million over that period, with no purchases from company insiders.

This creates a clear disconnect. The deal is framed as a forward-looking strategic move, but the recent trading activity from those with the closest view of the business suggests a lack of confidence in the near-term value of these food assets. When the people who know the most are selling, it's a classic red flag that the smart money isn't buying the hype.

Smart Money Signals: Phantom Stock vs. Real Cash

The proposed deal is a classic case of strategic talk versus skin-in-the-game action. Unilever's CEO has been vocal about the company's shift to premium segments, a move that aligns with the spin-off's logic. Yet his recent trades tell a different story. In February 2026, the CEO himself was among those selling, contributing to a net executive sell-off of -$2.44 million over the past 90 days. This is the smart money's vote: a lack of confidence in the near-term value of the food assets being carved out, even as the company's leadership talks up the future.

The contrast is stark when you look at the compensation structure for the other half of the deal. McCormick's CEO, Brendan Foley, received a routine equity award in March 2026: a grant of 684.220 phantom stock units. These units, valued at $0.0000 per unit, are a standard tool to tie his future wealth directly to the stock price. It's a classic alignment mechanism-his paycheck depends on the stock going up. This is the opposite of a cash sale; it's a bet on the future, not a profit-taking.

So where is the real money flowing? For Unilever, the answer is silence. There is no recent insider trading on record for the company. That absence speaks volumes. When executives are selling, it's a clear signal. When they are doing nothing, it's a different kind of signal-one of detachment or perhaps a wait-and-see stance. Meanwhile, the stock has been moving, with a 6.2% price increase over the same 90 days. The smart money isn't buying the stock, but it's not selling it either. The real action is happening elsewhere.

In fact, the most telling trades might be coming from a different group altogether. The evidence shows the stock has been recently traded by U.S. Congress members. While their motives are opaque, their activity suggests they may possess industry insight that the general public lacks. In a market where insiders are selling and the CEO is talking up a premium future, the real signal might be in the trades of those who aren't supposed to know. It's a reminder that the most valuable information often flows through channels the public doesn't monitor.

Institutional Accumulation and the 13F Watch

For the smart money, the real play is in the data, not the headlines. When it comes to institutional positioning, the picture is currently a blank slate. Major passive investors have not yet filed their latest 13F forms for the quarter, leaving institutional holdings information currently not available for McCormick. This silence is telling. In a market where whale wallets are constantly moving, the absence of new filings suggests a wait-and-see stance. Meanwhile, the analyst community is already weighing in with caution. A recent downgrade cited valuation concerns and trimmed earnings forecasts, a clear signal that the street is not yet convinced the food business is a bargain.

The setup for Unilever itself is one of measured growth, not explosive momentum. The company finished 2025 with underlying sales growth of 3.5%, a solid but not spectacular result. More importantly, its full-year update pointed to a slower start for 2026, with management positioning organic growth toward the lower end of its medium-term ambitions. This cautious guidance, coupled with recent analyst downgrades, has created a headwind. The stock's recent 3.2% drop reflects this lingering investor caution. In this environment, institutional accumulation is likely to be selective and patient.

Yet the potential value of the separation is what could eventually draw the smart money in. The deal, if it happens, would carve out a business worth tens of billions of dollars. That's a massive pool of capital that could be restructured and valued independently. The timeline provides a runway for positioning. With no move expected until 2027, there is ample time for both companies to execute their individual strategies and for institutions to digest the new standalone narratives. The current data gap isn't a lack of interest; it's a pause before the next wave of institutional accumulation begins.

Catalysts and Risks: The Pump and Dump Trap

The setup is classic. A strategic deal is announced, the stock pops, and insiders have already been selling. The real test is whether this becomes a coordinated pump and dump for the food assets, with insiders cashing out before the spin-off and institutional buyers left holding the bag. The near-term data will confirm or contradict this thesis.

First, watch for the formal 13F filing from major institutions after the deal is announced. Right now, institutional holdings for McCormick are currently not available, a data gap that suggests a wait-and-see stance. The first major 13F report after the deal's official launch will be critical. If we see a wave of accumulation from passive funds and hedge funds, it would signal the smart money is buying the spin-off narrative. Conversely, if the filings show net selling or continued silence, it would validate the insider sell-off as a warning sign that the food business carries hidden liabilities.

Second, monitor Unilever's 2026 earnings for signs of the food business's performance and any further insider selling. The company's full-year update already pointed to a slower start for 2026, with organic growth toward the lower end of its ambitions. The next quarterly report will show if the food segment is dragging on that growth. More importantly, watch the insider trading window. If executives continue to sell while the stock is elevated on deal hopes, it would be a clear signal they are taking money off the table before the spin-off. The recent pattern of a net executive sell-off of -$2.44 million over the past 90 days sets a concerning precedent.

The key risk is that the deal is a pump and dump for the food assets. The insiders at both companies have been selling, while the stock has been moving. The proposed separation is not expected until 2027, giving plenty of time for the narrative to build. If the smart money is already exiting, the institutional buyers who step in after the announcement could be getting stuck with the operational headwinds and margin pressures that the spin-off is meant to solve. The real money isn't in the hype; it's in watching who buys the story and who sells the stock.